The Evolving and Future Role of Plasma-Derived Therapies

Access Activity

Overview / Abstract:

Target Audience
This accredited activity is designed to address the educational needs of specialists who care for patients with hemophilia A.

Learning Objectives
After completing this activity, the participant should be better able to:

Summarize best practices in controversial aspects of hemophilia A care
Identify the current, evolving, and future roles for plasma-derived FVIII
Apply strategies to prevent and eradicate inhibitors in patients receiving FVIII

Expiration

Nov 26, 2020

Discipline(s)

Nursing CNE, Physician CME

Format

Online

Credits / Hours

0.5

Accreditation

ACCME

Presenters / Authors / Faculty

Robert Sidonio, Jr., MD
Assistant Professor of Pediatrics and Director of Clinical Operations
Hemostasis and Thrombosis Program
Emory University School of Medicine
Aflac Cancer and Blood Disorders Center
at Children’s Healthcare of Atlanta

Guy Young, MD
Director of the Hemostasis and Thrombosis Center
Children’s Hospital Los Angeles
Professor of Pediatrics
University of Southern California Keck School of Medicine

Sponsors / Supporters / Grant Providers

Supported by an educational grant from Kedrion Biopharma Inc..

Keywords / Search Terms

Relias LLC Hematology, Hemophilia A, Relias LLC Free CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map